110 related articles for article (PubMed ID: 14714280)
1. Effects of parathyroid hormone and alendronate alone or in combination in osteoporosis.
Sugiyama T; Tanaka H; Kawai S
N Engl J Med; 2004 Jan; 350(2):189-92; author reply 189-92. PubMed ID: 14714280
[No Abstract] [Full Text] [Related]
2. Effects of parathyroid hormone and alendronate alone or in combination in osteoporosis.
Miller PD
N Engl J Med; 2004 Jan; 350(2):189-92; author reply 189-92. PubMed ID: 14714279
[No Abstract] [Full Text] [Related]
3. Combination and sequential therapy for osteoporosis.
Heaney RP; Recker RR
N Engl J Med; 2005 Aug; 353(6):624-5. PubMed ID: 16093472
[No Abstract] [Full Text] [Related]
4. Exploiting and bypassing the bone remodeling cycle to optimize the treatment of osteoporosis.
Dempster DW
J Bone Miner Res; 1997 Aug; 12(8):1152-4. PubMed ID: 9258744
[No Abstract] [Full Text] [Related]
5. [Parathyroid and bone. Evidence and perspective of parathyroid therapy for patients with osteoporosis].
Wada S; Fukawa T; Kamiya S
Clin Calcium; 2007 Dec; 17(12):1888-94. PubMed ID: 18057665
[TBL] [Abstract][Full Text] [Related]
6. Alendronate: a bisphosphonate for treatment of osteoporosis.
Kirk JK; Spangler JG
Am Fam Physician; 1996 Nov; 54(6):2053-60. PubMed ID: 8900364
[TBL] [Abstract][Full Text] [Related]
7. Effects of parathyroid hormone and alendronate alone or in combination in osteoporosis.
Fuller KE
N Engl J Med; 2004 Jan; 350(2):189-92; author reply 189-92. PubMed ID: 14714278
[No Abstract] [Full Text] [Related]
8. Parathyroid hormone plus alendronate--a combination that does not add up.
Khosla S
N Engl J Med; 2003 Sep; 349(13):1277-9. PubMed ID: 14500803
[No Abstract] [Full Text] [Related]
9. One year of alendronate after one year of parathyroid hormone (1-84) for osteoporosis.
Black DM; Bilezikian JP; Ensrud KE; Greenspan SL; Palermo L; Hue T; Lang TF; McGowan JA; Rosen CJ;
N Engl J Med; 2005 Aug; 353(6):555-65. PubMed ID: 16093464
[TBL] [Abstract][Full Text] [Related]
10. Sequential parathyroid hormone/alendronate therapy for osteoporosis--robbing Peter to pay Paul?
Horwitz M; Stewart A; Greenspan SL
J Clin Endocrinol Metab; 2000 Jun; 85(6):2127-8. PubMed ID: 10852439
[No Abstract] [Full Text] [Related]
11. Treatment with alendronate plus calcium, alendronate alone, or calcium alone for postmenopausal low bone mineral density.
Bonnick S; Broy S; Kaiser F; Teutsch C; Rosenberg E; DeLucca P; Melton M
Curr Med Res Opin; 2007 Jun; 23(6):1341-9. PubMed ID: 17594775
[TBL] [Abstract][Full Text] [Related]
12. Alendronate and parathyroid hormone.
Muldowney FP
N Engl J Med; 2005 Dec; 353(24):2618-9; author reply 2618-9. PubMed ID: 16354902
[No Abstract] [Full Text] [Related]
13. Decimal point--osteoporosis therapy at the 10-year mark.
Strewler GJ
N Engl J Med; 2004 Mar; 350(12):1172-4. PubMed ID: 15028820
[No Abstract] [Full Text] [Related]
14. Ten years of alendronate treatment for osteoporosis in postmenopausal women.
Bjarnason NH
N Engl J Med; 2004 Jul; 351(2):190-2; author reply 190-2. PubMed ID: 15247362
[No Abstract] [Full Text] [Related]
15. Alendronate and indapamide alone or in combination in the management of hypercalciuria associated with osteoporosis: a randomized controlled trial of two drugs and three treatments.
Giusti A; Barone A; Pioli G; Girasole G; Siccardi V; Palummeri E; Bianchi G
Nephrol Dial Transplant; 2009 May; 24(5):1472-7. PubMed ID: 19075192
[TBL] [Abstract][Full Text] [Related]
16. [Parathyroid and bone. Role of parathyroid hormone in the treatment of osteoporosis].
Nakamura T
Clin Calcium; 2007 Dec; 17(12):1823-9. PubMed ID: 18057656
[TBL] [Abstract][Full Text] [Related]
17. Combination therapies for osteoporosis.
Jamal SA
J Am Pharm Assoc (2003); 2004; 44(2):119; author reply 119. PubMed ID: 15098843
[No Abstract] [Full Text] [Related]
18. Marked reduction of bone turnover by alendronate attenuates the acute response of bone resorption marker to endogenous parathyroid hormone.
Zikan V; Stepan JJ
Bone; 2009 Apr; 44(4):634-8. PubMed ID: 19150421
[TBL] [Abstract][Full Text] [Related]
19. Coming to grips with bone loss.
Marx J
Science; 2004 Sep; 305(5689):1420-2. PubMed ID: 15353792
[No Abstract] [Full Text] [Related]
20. The anabolic action of intermittent PTH in combination with cathepsin K inhibitor or alendronate differs depending on the remodeling status in bone in ovariectomized mice.
Yamane H; Sakai A; Mori T; Tanaka S; Moridera K; Nakamura T
Bone; 2009 Jun; 44(6):1055-62. PubMed ID: 19303837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
